Matthew M. Harmelink MD
Assistant Professor, Department of Neurology, Division of Child Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin
Dr. Matthew Harmelink is an Assistant Professor with an expertise in neuromuscular medicine in the Department of Neurology, Division of Child Neurology at the Medical College of Wisconsin. He completed his Pediatric Residency at the University of Calfornia, Irvine, Child Neurology Fellowship at the Medical College of Wisconsin/Children’s Wisconsin, and Neuromuscular Medicine Fellowship at University of California, Los Angeles. Currently, he serves at the Director of the Pediatric Neuromuscular Program, Co-Director of the Neurogenetic Clinic, and Residency Director for the Child Neurology Training Program. He is currently the local PI for various neuromuscular pharmaceutical interventional trials and engages in research regarding efficacy in evaluation and treatment of pediatric neuromuscular diseases.
Disclosures
Dr. Harmelink has served on the advisory boards for Sarepta Inc, PTC Inc, Biogen Inc, and Avexis Inc. He is a consultant for Biogen Inc, as well as Emerging Therapy Solutions. Dr. Harmelink has infrastructure grants from MDA and PPMD and is a sub/co-I on projects funded by CureSMA. He also has an unrestricted educational grant from Sarepta. Dr. Harmelink is an unpaid board member of Three Gaits Inc.